Transactions on Additive Manufacturing Meets Medicine
Vol. 1 No. 1 (2019): Trans. AMMM
https://doi.org/10.18416/AMMM.2019.1909S03P13

Scaffolds, Implants and Drug Delivery Systems

Stereolithographic 3D printing (SLA 3DP) of pharmaceutical tablets
3DP tablets

Main Article Content

Eng Leong Tan (Department of Pharmacy, National University of Singapore, Singapore), Paul Ho (Department of Pharmacy, National University of Singapore, Singapore and Centre for Additive Manufacturing, National University of Singapore, Singapore)

Copyright (c) 2019 AMMM

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

We evaluated the applicability of SLA 3DP in making pharmaceutical tablets. Adding alizarin dye in the printing polymers improved print resolution through minimizing light scattering. 3DP tablets were evaluated for weight deviation, uniformity in drug content and dissolution profiles. 3DP tablets were determined to be uniform in weight and drug content based on European Pharmacopoeia criteria. Tablets with different sizes and shapes were printed with consistency. A lower PEGDA to PEG ratio, addition of xylitol as disintegrant and change in tablet design to improve the surface area-to-volume ratio, were explored to improve rate of drug release from 3DP tablets.

Article Details

How to Cite

Tan, E. L., & Ho, P. (2019). Stereolithographic 3D printing (SLA 3DP) of pharmaceutical tablets: 3DP tablets. Transactions on Additive Manufacturing Meets Medicine, 1(1). https://doi.org/10.18416/AMMM.2019.1909S03P13